Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.
Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Univercells positions itself as a global partner for developing biomanufacturing/biosimilar solution, going from the process design, to the selection of the best technologies (USP, DSP, filing technologies, etc), to the design of the clinical plan, the process development, the technology transfer, the facility construction or the training of the staff.
|Employees (est.) (Mar 2020)||152||(+6%)|
Univercells total Funding
Univercells latest funding size
Time since last funding
|2 years ago|
|Takeda Ventures, Bill & Melinda Gates Foundation, Global Health Investment Fund|
Univercells has 304 Twitter Followers. The number of followers has increased 3.5% month over month and increased 6.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Univercells founded?
Univercells was founded in 2013.
Who are Univercells key executives?
Univercells's key executives are Hugues Bultot, Vincent Vanderborght and Cécile Jacoby.
How many employees does Univercells have?
Univercells has 152 employees.
Who are Univercells competitors?
Competitors of Univercells include Centrexion, Principia BioPharma and Rapid Micro Biosystems.
Where is Univercells headquarters?
Univercells headquarters is located at Rue Auguste Piccard 48, Charleroi.
Where are Univercells offices?
Univercells has offices in Charleroi, Nivelles and Woluwe-Saint-Pierre.
How many offices does Univercells have?
Univercells has 3 offices.
Receive alerts for 300+ data fields across thousands of companies